ClinicalTrials.govpublic full text
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
non-alcoholic fatty liver disease, type 2 diabetes, metabolic syndrome
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 411309
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.